Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

TNFAIP3-interacting protein 1

The TNIP1 gene encodes a protein that is involved in transcription control. Mutations are found in autoimmune diseases such as psoriatric and rheumatoid arthritis and lupus erythematodes. Epigenetic modification of this gene was associated with dyslipidemia.

Genetests:

Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Research Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

Epigenetic dyslipidemia
ABCG1
CPT1A
MIR33B
SREBF1
TNIP1
TNNT1

References:

1.

Braun KV et al. (2016) The role of DNA methylation in dyslipidaemia: A systematic review.

external link
2.

Pfeiffer L et al. (2015) DNA methylation of lipid-related genes affects blood lipid levels.

external link
3.

Fukushi M et al. (1999) Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression.

external link
4.

Zhang S et al. (2002) A new ERK2 binding protein, Naf1, attenuates the EGF/ERK2 nuclear signaling.

external link
5.

El Bakkouri K et al. (2005) Adenoviral gene transfer of the NF-kappa B inhibitory protein ABIN-1 decreases allergic airway inflammation in a murine asthma model.

external link
6.

Oshima S et al. (2009) ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development.

external link
7.

Gurevich I et al. (2009) Liganded RARalpha and RARgamma interact with but are repressed by TNIP1.

external link
8.

Orphanet article

Orphanet ID 369132 external link
9.

NCBI article

NCBI 10318 external link
10.

OMIM.ORG article

Omim 607714 external link
11.

Wikipedia article

Wikipedia EN (TNIP1) external link
Update: Aug. 14, 2020
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues